bortezomib	bortezomib	Npmsn
Vortemyel	Vortemyel	Npmsn
praš	prati	Vmr2s
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
1	1	Mdc
x3	xi	Agpnsny
,	,	Z
5	5	Mdc
mg	mg	Y
/	/	Z
10	10	Mdc
ml	ml	Y
L01XX32	L01XX32	X
062	062	Mdc
bortezomib	bortezomi	Ncmpg
Bortezomib	Bortezomib	Npfsg
Alpha-Medical	Alpha-Medical	Npfsg
praš	prati	Vmr2s
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
1	1	Mdc
x3	xi	Agpnsny
,	,	Z
5	5	Mdc
mg	mg	Y
L01XX32	L01XX32	Mdc
071	071	Mdc
bortezomib	bortezomi	Ncmpg
Velcade	Velcada	Npfsg
praš	prati	Vmr2s
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
1	1	Mdc
x3	xi	Agpnsny
,	,	Z
5	5	Mdc
mg	mg	Y
/	/	Z
10	10	Mdc
ml	ml	Y
L01XX46	L01XX46	X
161	161	Mdc
olaparib	olapari	Ncmpg
Lynparza	Lynparz	Npmsg
caps	caps	Pi-mpi
.	.	Z
tvrda	tvrd	Agpfsny
448	448	Mdc
x50	xi	Agpmsgy
mg	mg	Agpmsgy
L02BB04	L02BB0	Npmsg
161	161	Mdc
enzalutamid	enzalutami	Ncmpg
Xtandi	Xtanda	Npfsd
caps	caps	Agpfsny
.	.	Z
meka	mek	Agpfsny
112	112	Mdc
x40	xi	Agpmsgy
mg	mg	Agpmsgy
L02BX03	L02BX0	Npmsg
161	161	Mdc
abirateron	abirateron	Sg
Zytiga	Zyti	Npmsg
tbl	tbl	Ncmsan
.	.	Z
120	120	Mdc
x250	x250	Mdc
mg	mg	Agpmsgy
L03AB07	L03AB0	Npmsg
062	062	Mdc
interferon	interferon	Ncmsan
beta-1a	beta-1	Npmsg
Avonex	Avone	Npmsg
praš	prati	Vmr2s
.	.	Z
i	i	Cc
otap	otap	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
4	4	Mdc
x0	xi	Agpnsny
,	,	Z
5	5	Mdc
ml	ml	Y
(	(	Z
30	30	Mdc
mcg	mce	Ncnpg
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
)	)	Z
,	,	Z
4	4	Mdc
štrc	štr	Ncmpg
.	.	Z
napunj	napunj	Ncmsan
.	.	Z
i	i	Cc
4	4	Mdc
igle	igla	Ncfsg
L03AB07	L03AB07	Mdc
072	072	Mdc
interferon	interferon	Ncmsan
beta-1a	beta-1	Npmsg
Rebif	Rebi	Npmsg
šprica	špricati	Vmr3s
3	3	Mdc
x22	x22	Mdc
mcg	mc	Ncmpg
(	(	Z
6	6	Mdc
mil.	mil.	Y
i.	i.	Y
j.	j.	Y
)	)	Z
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
L03AB07	L03AB07	Mdc
073	073	Mdc
interferon	interferon	Ncmsan
beta-1a	beta-1	Npmsg
Rebif	Rebi	Npmsg
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Ncmsan
.	.	Z
12	12	Mdc
x44	x44	Mdc
mcg	mcg	Ncfpg
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
L03AB07	L03AB07	Mdc
074	074	Mdc
interferon	interferon	Ncmsan
beta-1a	beta-1	Npmsg
Rebif	Rebi	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
u	u	Sl
ulošku	uložak	Ncmsl
,	,	Z
4	4	Mdc
x132	x132	Mdc
mcg	mcg	Ncfpg
/	/	Z
1,5	1,5	Mdc
ml	ml	Y
(	(	Z
44	44	Mdc
mcg	mce	Ncnpg
/	/	Z
0,5	0,5	Mdc
ml	ml	Ncfpg
)	)	Z
L03AB08	L03AB08	Mdc
081	081	Mdc
interferon	interferon	Ncmsan
beta-1b	beta-1	Npmsg
Extavia	Extavi	Npmsg
praš	prati	Vmr2s
.	.	Z
i	i	Cc
otap	otap	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Ncmsan
.	.	Z
15	15	Mdc
x250	x250	Mdc
mcg	mcg	Ncfpg
/	/	Z
ml	ml	Y
+	+	Z
ExtaviPro	extavipr	Agpnsny
30	30	Mdc
G	g	Y
set	set	Ncmsan
za	za	Sa
primjenu	primjena	Ncfsa
L03AB08	l03ab0i	Agpfsgy
092	092	Mdc
interferon	interferon	Ncmsan
beta-1b	beta-1	Npmsg
Betaferon	Betafero	Npmsg
praš	prati	Vmr2s
.	.	Z
i	i	Cc
otap	otap	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
1	1	Mdc
x300	x300	Mdc
mcg	mcg	Ncfpg
/	/	Z
9,6	9,6	Mdc
MIU	MI	Npmsl
(	(	Z
250	250	Mdc
mg	mg	Y
/	/	Z
ml	ml	Y
=	=	Z
8	8	Mdc
MIU	MI	Npmsl
)	)	Z
L03AB10	L03AB10	Mdc
081	081	Mdc
peginterferon	peginterferon	Y
alfa-2b	alfa-2b	Agpmsny
Pegintron	pegintron	Agpmsny
injektor	injektor	Ncmsn
s	sa	Si
napunj	nap	Ncmpi
.	.	Z
stakl	stakl	Ncmsan
.	.	Z
patr	patr	Ncmsan
.	.	Z
,	,	Z
1	1	Mdc
x50	x50	Mdc
mcg	mi	Agpmsgy
L03AB10	L03AB10	Mdc
082	082	Mdc
peginterferon	peginterferoa	Ncfpg
alfa-2b	alfa-2b	Agpmsny
Pegintron	pegintron	Agpmsny
injektor	injektor	Ncmsn
s	sa	Si
napunj	nap	Ncmpi
.	.	Z
stakl	stakl	Ncmsan
.	.	Z
patr	patr	Ncmsan
.	.	Z
,	,	Z
1	1	Mdc
x80	x80	Mdc
mcg	mi	Agpmsgy
L03AB10	L03AB10	Mdc
083	083	Mdc
peginterferon	peginterferoa	Ncfpg
alfa-2b	alfa-2b	Agpmsny
Pegintron	pegintron	Agpmsny
injektor	injektor	Ncmsn
s	sa	Si
napunj	nap	Ncmpi
.	.	Z
stakl	stakl	Ncmsan
.	.	Z
patr	patr	Ncmsan
.	.	Z
,	,	Z
1	1	Mdc
x100	x100	Mdc
mcg	mi	Agpmsgy
L03AB10	L03AB10	Mdc
084	084	Mdc
peginterferon	peginterferoa	Ncfpg
alfa-2b	alfa-2b	Agpmsny
Pegintron	pegintron	Agpmsny
injektor	injektor	Ncmsn
s	sa	Si
napunj	nap	Ncmpi
.	.	Z
stakl	stakl	Ncmsan
.	.	Z
patr	patr	Ncmsan
.	.	Z
,	,	Z
1	1	Mdc
x120	x120	Mdc
mcg	mi	Agpmsgy
L03AB10	L03AB10	Mdc
085	085	Mdc
peginterferon	peginterferoa	Ncfpg
alfa-2b	alfa-2b	Agpmsny
Pegintron	pegintron	Agpmsny
injektor	injektor	Ncmsn
s	sa	Si
napunj	nap	Ncmpi
.	.	Z
stakl	stakl	Ncmsan
.	.	Z
patr	patr	Ncmsan
.	.	Z
,	,	Z
1	1	Mdc
x150	x150	Mdc
mcg	mi	Agpmsgy
L03AB11	L03AB11	Mdc
061	061	Mdc
peginterferon	peginterferon	Sg
alfa-2a	alfa-2	Npmsg
Pegasys	Pegasy	Npmsg
štrc	štrc	Ncmsan
.	.	Z
1	1	Mdc
x135	x135	Mdc
mcg	mcg	Ncfpg
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
i	i	Cc
igla	igla	Ncfsn
L03AB11	l03abi	Agpmsgy
063	063	Mdc
peginterferon	peginterferon	Sg
alfa-2a	alfa-2	Npmsg
Pegasys	Pegasy	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
1	1	Mdc
x135	x135	Mdc
mcg	mcg	Ncfpg
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
s	sa	Si
pričvršćenom	pričvršćen	Agpfsiy
iglom	igla	Ncfsi
L03AB11	L03AB11	Mdc
064	064	Mdc
peginterferon	peginterferon	Sg
alfa-2a	alfa-2	Npmsg
Pegasys	Pegasy	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
1	1	Mdc
x180	x180	Mdc
mcg	mcg	Ncfpg
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
s	sa	Si
pričvršćenom	pričvršćen	Agpfsiy
iglom	igla	Ncfsi
L03AX04	L03AX04	X
051	051	Mdc
pegademaza	pegademaz	Ncmpg
L03AX13	L03AX1	Npmsg
062	062	Mdc
glatiramer	glatiramer	Y
acetat	acetat	Ncmsan
(	(	Z
kopolimer-1	kopolimer-1	Mds
)	)	Z
Copaxone	copaxo	Aspmpgy
otop	oto	Ncmpg
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Ncmsan
.	.	Z
28	28	Mdc
x20	x20	X
mg	mg	Y
/	/	Z
ml	ml	Cc
L03AX13	L03AX13	Mdc
063	063	Mdc
glatiramer	glatiramer	Y
acetat	acetat	Ncmsan
(	(	Z
kopolimer-1	kopolimer-1	Mds
)	)	Z
Copaxone	copaxo	Aspmpgy
otop	oto	Ncmpg
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Ncmsan
.	.	Z
12	12	Mdc
x40	x40	X
mg	mg	Y
/	/	Z
ml	ml	Cc
L03AX16	L03AX16	Mdc
061	061	Mdc
pleriksafor	pleriksafor	Y
Mozobil	Mozobi	Npmpg
otop	oto	Ncmpg
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
boč	boč	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
1	1	Mdc
x24	x24	X
mg	mg	Xf
/	/	Z
1,2	1,2	Mdc
ml	ml	Y
(	(	Z
20	20	Mdc
mg	mg	Y
/	/	Z
ml	ml	Y
)	)	Z
L04AA23	L04AA23	Mdc
061	061	Mdc
natalizumab	natalizumab	Y
Tysabri	Tysabra	Npfsd
konc	konc	Ncmsan
.	.	Z
otop	o	Agcfpny
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	boč	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
1	1	Mdc
x15	x15	Xf
ml	ml	Xf
(	(	Z
20	20	Mdc
mg	mg	Y
/	/	Z
1	1	Mdc
ml	ml	Ncfpg
)	)	Z
L04AA27	L04AA27	X
161	161	Mdc
fingolimod	fingolimod	Sg
Gilenya	Gileny	Npmsg
caps	caps	Y
.	.	Z
tvrda	tvrd	Agpfsny
28	28	Mdc
x0	x0	Y
,	,	Z
5	5	Mdc
mg	mg	Y
L04AA31	L04AA31	X
161	161	Mdc
teriflunomid	teriflunomid	Ncmsan
Aubagio	aubagiti	Vmp-sm
tbl	tbl	Ncmsan
.	.	Z
film	film	Ncmsan
obl	obl	Ncmsan
.	.	Z
28	28	Mdc
x14	x14	Xf
mg	mg	Xf
L04AA32	L04AA32	Mdc
161	161	Mdc
apremilast	apremilast	Ncfpg
Otezla	Otezl	Npmsg
tbl	tbl	Ncmsan
.	.	Z
film	film	Ncmsan
obl	obl	Ncmsan
.	.	Z
(	(	Z
4	4	Mdc
x10	x10	Xf
mg	mg	Xf
)	)	Z
+	+	Z
(	(	Z
4	4	Mdc
x20	x20	Xf
mg	mg	Xf
)	)	Z
+	+	Z
(	(	Z
19	19	Mdc
x30	x30	Xf
mg	mg	Xf
)	)	Z
L04AA32	L04AA32	Mdc
162	162	Mdc
apremilast	apremilas	Ncmpg
Otezla	Otezl	Npmsg
tbl	tbl	Ncmsan
.	.	Z
film	film	Ncmsan
obl	obl	Ncmsan
.	.	Z
56	56	Mdc
x30	x30	Xf
mg	mg	Xf
L04AA32	L04AA32	Mdc
163	163	Mdc
apremilast	apremilast	Ncfpg
Otezla	Otezl	Npmsg
tbl	tbl	Ncmsan
.	.	Z
film	film	Ncmsn
obl	obe	Ncnsg
.	.	Z
168	168	Mdc
x30	x30	Xf
mg	mg	Xf
L04AA33	L04AA33	X
061	061	Mdc
vedolizumab	vedolizumab	Y
Entyvio	Entyvio	Npmsn
praš	prati	Vmr2s
.	.	Z
za	za	Sa
konc	konc	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	boč	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
1	1	Mdc
x300	x300	Mdc
mg	mg	Y
L04AA34	L04AA34	X
061	061	Mdc
alemtuzumab	alemtuzuma	Ncmpg
Lemtrada	Lemtrad	Npmsg
konc	konc	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	boč	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
1	1	Mdc
x12	x12	X
mg	mg	Xf
/	/	Z
1,2	1,2	Mdc
ml	ml	Y
L04AB01	L04AB01	Mdc
060	060	Mdc
etanercept	etanercept	Ncfpg
Enbrel	Enbre	Npmsg
praš	prati	Vmr2s
.	.	Z
i	i	Cc
otap	otap	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
4	4	Mdc
x25	x25	Xf
mg	mg	Xf
+4	+4	Xf
napunj	napunj	Ncmsan
.	.	Z
štrc	štrc	Ncmsan
.	.	Z
s	sa	Si
otap	o	Ncmpi
.	.	Z

L04AB01	L04AB01	Mdc
061	061	Mdc
etanercept	etanercept	Ncfpg
Enbrel	Enbre	Npmpg
otop	oto	Ncmpg
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
4	4	Mdc
x50	x50	X
mg	mg	Xf
/	/	Z
ml	ml	Y
+	+	Z
8	8	Mdc
jast	jast	Ncfpg
.	.	Z

L04AB01	L04AB01	Mdc
063	063	Mdc
etanercept	etanercept	Y
Enbrel	Enbrel	Npmsn
(	(	Z
MyClick	MyClick	Npmsn
)	)	Z
otop	o	Agcfpny
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
brizg	brizg	Ncnsv
.	.	Z
napunj	napunj	Rgp
.	.	Z
4	4	Mdc
x50	x50	X
mg	mg	Xf
/	/	Z
ml	ml	Y
+	+	Z
4	4	Mdc
jast	jast	Ncfpg
.	.	Z
natop	natoi	Agpfsny
.	.	Z
alkoholom	alkohol	Ncmsi
L04AB01	L04AB01	X
064	064	Mdc
etanercept	etanercept	Ncfpg
Enbrel	Enbre	Npmsg
praš	prati	Vmr2s
.	.	Z
i	i	Cc
otap	otap	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
za	za	Sa
ped	ped	Ncmsan
.	.	Z
upor	upor	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
4	4	Mdc
x10	x10	Xf
mg	mg	Xf
+4	+4	Xf
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Pq3n-n
.	.	Z
s	sa	Si
otap	o	Ncmpi
.	.	Z
+8	+8	Xf
jast	jast	Xf
.	.	Z

L04AB02	L04AB02	Mdc
061	061	Mdc
infliksimab	infliksimab	Y
Remicade	Remicada	Npfsg
lio	liti	Vmp-sm
boč	boč	Ncmsan
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
1	1	Mdc
x100	x100	Mdc
mg	mg	Agpmsgy
L04AB02	L04AB0	Npmsg
071	071	Mdc
infliksimab	infliksima	Ncmpg
Inflectra	Inflectr	Npmsg
praš	prati	Vmr2s
.	.	Z
za	za	Sa
konc	konc	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	boč	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
1	1	Mdc
x100	x100	Mdc
mg	mg	Agpmsgy
L04AB02	L04AB0	Npmsg
081	081	Mdc
infliksimab	infliksima	Ncmpg
Remsima	Remsim	Npmsg
praš	prati	Vmr2s
.	.	Z
za	za	Sa
konc	konc	Ncmsan
.	.	Z
za	za	Sa
otop	otop	Ncmsan
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	boč	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
1	1	Mdc
x100	x100	Mdc
mg	mg	Agpmsgy
L04AB04	L04AB0	Npmsg
061	061	Mdc
adalimumab	adalimuma	Ncmpg
Humira	Humir	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
2	2	Mdc
x40	x40	X
mg	mg	Xf
/	/	Z
0,8	0,8	Mdc
ml	ml	Y
L04AB04	L04AB04	Mdc
062	062	Mdc
adalimumab	adalimuma	Ncmpg
Humira	Humir	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
za	za	Sa
pedij	pedij	Ncmsan
.	.	Z
uporabu	uporaba	Ncfsa
,	,	Z
boč	boč	Ncmsan
.	.	Z
2	2	Mdc
x40	x40	X
mg	mg	Xf
/	/	Z
0,8	0,8	Mdc
ml	ml	Y
L04AB04	L04AB04	Mdc
063	063	Mdc
adalimumab	adalimuma	Ncmpg
Humira	Humir	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
stakl	stakl	Rgp
.	.	Z
2	2	Mdc
x40	x40	X
mg	mg	Xf
/	/	Z
0,4	0,4	Mdc
ml	ml	Y
L04AB04	L04AB04	Mdc
064	064	Mdc
adalimumab	adalimuma	Ncmpg
Humira	Humir	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
brizg	brizg	Ncnsv
.	.	Z
napunj	napunj	Rgp
.	.	Z
2	2	Mdc
x40	x40	X
mg	mg	Xf
/	/	Z
0,4	0,4	Mdc
ml	ml	Y
L04AB05	L04AB05	Mdc
061	061	Mdc
certolizumab	certolizuma	Ncmpg
pegol	pegol	Cc
Cimzia	Cimzi	Npmpg
otop	oto	Ncmpg
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
2	2	Mdc
x200	x200	Mdc
mg	mg	Y
/	/	Z
ml	ml	Cc
L04AB06	L04AB06	Mdc
061	061	Mdc
golimumab	golimuma	Ncmpg
Simponi	simpon	Agpmsny
otop	otop	Ncmsn
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
brzig	brzig	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
1	1	Mdc
x50	x50	X
mg	mg	Xf
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
L04AB06	L04AB06	Mdc
062	062	Mdc
golimumab	golimuma	Ncmpg
Simponi	simpon	Agpmsny
otop	otop	Ncmsn
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
,	,	Z
brizg	brizg	Ncnsv
.	.	Z
napunj	napunj	Rgp
.	.	Z
1	1	Mdc
x100	x100	Mdc
mg	mg	Y
/	/	Z
ml	ml	Cc
L04AC05	L04AC05	Mdc
061	061	Mdc
ustekinumab	ustekinuma	Ncmpg
Stelara	Stelar	Npmsg
otop	otop	Mro
.	.	Z
za	za	Sa
inj	inj	Ncmsan
.	.	Z
štrc	štrc	Ncmsan
.	.	Z
napunj	napunj	Rgp
.	.	Z
1	1	Mdc
x45	x45	X
mg	mg	Xf
/	/	Z
0,5	0,5	Mdc
ml	ml	Y
L04AC07	L04AC07	X
061	061	Mdc
tocilizumab	tocilizuma	Ncmpg
RoActemra	roactemrati	Vmr3s
konc	konc	Ncmsan
.	.	Z
otop	o	Agcfpny
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
1	1	Mdc
x80	x80	X
mg	mg	Xf
/	/	Z
4	4	Mdc
ml	ml	Cc
L04AC07	L04AC07	Mdc
062	062	Mdc
tocilizumab	tocilizuma	Ncmpg
RoActemra	roactemrati	Vmr3s
konc	konc	Ncmsan
.	.	Z
otop	o	Agcfpny
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z
1	1	Mdc
x200	x200	Mdc
mg	mg	Y
/	/	Z
10	10	Mdc
ml	ml	Y
L04AC07	L04AC07	X
063	063	Mdc
tocilizumab	tocilizuma	Ncmpg
RoActemra	roactemrati	Vmr3s
konc	konc	Ncmsan
.	.	Z
otop	o	Agcfpny
.	.	Z
za	za	Sa
inf	inf	Ncmsan
.	.	Z
,	,	Z
boč	bo	Mlompg
.	.	Z

